Evidence map›Paper›PMID 29358691›Full record

ArticleNature communications2018

Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes.

Sílvia Bonàs-Guarch, Marta Guindo-Martínez, Irene Miguel-Escalada, Niels Grarup, David Sebastian, Elias Rodriguez-Fos, Friman Sánchez, Mercè Planas-Fèlix, Paula Cortes-Sánchez, Santi González and 33 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 76 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 7 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 7 syntheses or guidelines pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

43 authors at 14 institutions in 4 countries.

Sílvia Bonàs-GuarchBarcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, 08034, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2085-7488
Marta Guindo-MartínezBarcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, 08034, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8099-9170
Irene Miguel-EscaladaGenomic Programming of Beta-cells Laboratory, Institut d'Investigacions August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.ORCID http://orcid.org/0000-0003-3461-6404
Niels GrarupThe Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-5526-1070
David SebastianInstituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029, Madrid, Spain.
Elias Rodriguez-FosBarcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, 08034, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2555-0178
Friman SánchezBarcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, 08034, Barcelona, Spain.
Mercè Planas-FèlixBarcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, 08034, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8267-576X
Paula Cortes-SánchezBarcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, 08034, Barcelona, Spain.
Santi GonzálezBarcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, 08034, Barcelona, Spain.ORCID http://orcid.org/0000-0001-5685-4580
Pascal TimshelThe Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.
Tune H PersThe Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.
Claire C MorganSection of Epigenomics and Disease, Department of Medicine, Imperial College London, London, W12 0NN, UK.ORCID http://orcid.org/0000-0002-8191-3738
Ignasi MoranSection of Epigenomics and Disease, Department of Medicine, Imperial College London, London, W12 0NN, UK.ORCID http://orcid.org/0000-0002-3307-7106
Goutham AtlaGenomic Programming of Beta-cells Laboratory, Institut d'Investigacions August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.
Juan R GonzálezISGlobal, Centre for Research in Environmental Epidemiology (CREAL), 08003, Barcelona, Spain.
Montserrat PuiggrosBarcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, 08034, Barcelona, Spain.ORCID http://orcid.org/0000-0001-5034-7924
Jonathan MartíComputer Sciences Department, Barcelona Supercomputing Center (BSC-CNS), 08034, Barcelona, Spain.
Ehm A AnderssonThe Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.
Carlos DíazComputer Sciences Department, Barcelona Supercomputing Center (BSC-CNS), 08034, Barcelona, Spain.
Rosa M BadiaComputer Sciences Department, Barcelona Supercomputing Center (BSC-CNS), 08034, Barcelona, Spain.
Miriam UdlerPrograms in Metabolism and Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA.
Aaron LeongDiabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA.
Varindepal KaurDiabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA.
Jason FlannickPrograms in Metabolism and Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA.
Torben JørgensenResearch Centre for Prevention and Health, Capital Region of Denmark, DK-2600, Glostrup, Denmark.
Allan LinnebergResearch Centre for Prevention and Health, Capital Region of Denmark, DK-2600, Glostrup, Denmark.ORCID http://orcid.org/0000-0002-0994-0184
Marit E JørgensenSteno Diabetes Center, 2820, Gentofte, Denmark.ORCID http://orcid.org/0000-0001-8356-5565
Daniel R WitteDepartment of Public Health, Aarhus University, DK-8000, Aarhus C, Denmark.
Cramer ChristensenMedical department, Lillebaelt Hospital, 7100, Vejle, Denmark.
Ivan BrandslundDepartment of Clinical Biochemistry, Lillebaelt Hospital, 7100, Vejle, Denmark.
Emil V AppelThe Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.
Robert A ScottMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Jian'an LuanMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Claudia LangenbergMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Nicholas J WarehamMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Oluf PedersenThe Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.
Antonio ZorzanoInstituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029, Madrid, Spain.
Jose C FlorezPrograms in Metabolism and Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA.
Torben HansenThe Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-8748-3831
Jorge FerrerGenomic Programming of Beta-cells Laboratory, Institut d'Investigacions August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5959-5729
Josep Maria MercaderBarcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, 08034, Barcelona, Spain. mercader@broadinstitute.org.ORCID http://orcid.org/0000-0001-8494-3660
David TorrentsBarcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, 08034, Barcelona, Spain. david.torrents@bsc.es.ORCID http://orcid.org/0000-0002-6086-9037
Barcelona Supercomputing Center · ESUniversity of Copenhagen · DKInstituto de Salud Carlos III · ESBroad Institute · USUniversity of Cambridge · GBImperial College London · GBMassachusetts General Hospital · USStatens Serum Institut · DKAarhus University · DKInstitució Catalana de Recerca i Estudis Avançats · ESLillebaelt Hospital · DKSteno Diabetes Centers · DKUniversitat Pompeu Fabra · ESUniversity of Southern Denmark · DK

Funding

Medical Research Council MC_UU_12015/1Medical Research Council MR/L02036X/1Wellcome Trust
6 · The paper itself

Abstract

The reanalysis of existing GWAS data represents a powerful and cost-effective opportunity to gain insights into the genetics of complex diseases. By reanalyzing publicly available type 2 diabetes (T2D) genome-wide association studies (GWAS) data for 70,127 subjects, we identify seven novel associated regions, five driven by common variants (LYPLAL1, NEUROG3, CAMKK2, ABO, and GIP genes), one by a low-frequency (EHMT2), and one driven by a rare variant in chromosome Xq23, rs146662057, associated with a twofold increased risk for T2D in males. rs146662057 is located within an active enhancer associated with the expression of Angiotensin II Receptor type 2 gene (AGTR2), a modulator of insulin sensitivity, and exhibits allelic specific activity in muscle cells. Beyond providing insights into the genetics and pathophysiology of T2D, these results also underscore the value of reanalyzing publicly available data using novel genetic resources and analytical approaches.

Indexed as

Genome-Wide Association StudyPolymorphism, Single NucleotideAllelesChromosomes, Human, XGene Regulatory NetworksGenetic Predisposition to DiseaseGenotypeHumansInsulin ResistanceMaleModels, GeneticRisk Factors

Identifiers

PMID29358691
PMCPMC5778074
OpenAlexW2783331323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.